Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs TORM plc (TRMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs TORM plc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while TORM plc trades at $39.12 (market cap $4.12B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 7.5× TORM plc's market cap, and TORM plc pays the higher dividend (11.07%). Which is the better fit depends on your goals.
| GEHC | TRMD | |
|---|---|---|
Market Cap | $30.93B | $4.12B |
Volume | 5,033,451 | 2,428,655 |
Sector | Health | Industrials |
52-Week High | $88.16 | $41.11 |
52-Week Low | $59.48 | $19.39 |
Enterprise Value | $39.39B | $4.83B |
Dividend Yield | 0.23% | 11.07% |
Typical Hold Time | — | 23 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
TRMD trades at $41.11, up 0.46% with strong bullish technical signals from moving averages. The company shows robust fundamentals with a P/E of 6.76, net income margin of 35.52%, and ROE of 26.84%. Recent earnings show mixed results with Q2 2026 missing expectations but strong year-over-year growth projected. Analyst consensus is unanimously bullish with 100% buy ratings. The stock faces headwinds from declining spot rates as noted in recent analysis.
Outlook remains positive based on strong profitability and valuation metrics, though near-term pressure from freight rate declines presents risk. The dividend yield of approximately 5.8% provides income support. Institutional accumulation and solid cash flow generation support the bullish case, but investors should monitor tanker rate trends closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
